Darusentan
| CAS No. | 171714-84-4 | Cat. No. | BCP13024 |
| Name | Darusentan | ||
| Synonyms | LU-135252; LU 135252; HMR-4005;HMR4005;HMR 4005;LU135252; | ||
| Formula | C22H22N2O6 | M. Wt | 410.42 |
| Description | Darusentan is a selective endothelin-1 receptor A inhibitor. Darusentan is identified as the treatment of congestive heart failure, hypertension and cancers. It blocks endothelin ETA receptor thus results in an increase of sodium and potassium excretion in aging rats. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Endothelin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.